Integrated Child Health Records or better known as iCHR backed by the Delhi-based Oxyent Technologies Private Limited has recently been in news for raising a whooping amount of Rs 3 crore (over $450,000) from a senior partner with financial advisory firm Ernst & Young, now known as EY. And that’s not all. They have no plans of stopping anytime early. Why? Reason being the thirst for success.
They are already in talks with two early-stage venture capital firms of Singapore and the US to raise its second round of funding for expanding its operations within India and also to African countries. The funding from next round has been estimated around Rs 30 crore ($4.5 million).
iCHR is one of the first start-ups that aims at bringing medical help closer to you by the awesome idea of integrating doctors, hospitals and medical help all in one application for the parents.They provide automated vaccination records and monitors the growth schedule apart from helping maintain data for research purposes.
With apps already doing good in the Play Store and the App Store, iCHR is planning to use a major portion of the funding for marketing camapigns in order to make their application version more successful. Sounds like a usual start-up recipe? Then what makes it different?
Simple, Efficient, Effective, Flexible are what they have to say about their application but what we see is the target they have achieved so far. Already in association with the Apollo Hospitals, iCHR targets private hospitals and clinics in Delhi-NCR and plan to scale up by targeting big hospital chains in Delhi and across India.
Currently, iCHR claims to have over 2,500 patients on its platform. Along with long-term surveillance of a child’s growth, the digital platform helps detect obesity and malnutrition in urban and rural populations, respectively.
Child birth is one of the most celecrated events in a family and iCHR here ensure the safety of your child. With a noble cause in mind and an awesome working strategies, they have already come a long way with the funding and client gain. Hoping to see them dp good in the future as well.
